Cyclerion Therapeutics, Inc.CYCNNASDAQ
Loading
Book Value/Share Growth Recovery in ProgressRecovering
Percentile Rank81
Year-over-Year Change
Year-over-year book value per share growth
Percentile
P81
Within normal range
vs 2Y Ago
0x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q3 2025 | 5.98% |
| Q2 2025 | -18.76% |
| Q1 2025 | -1.18% |
| Q4 2024 | 7.11% |
| Q3 2024 | -7.25% |
| Q2 2024 | -12.05% |
| Q1 2024 | -12.79% |
| Q4 2023 | -13.70% |
| Q3 2023 | 134.26% |
| Q2 2023 | 25.12% |
| Q1 2023 | -62.45% |
| Q4 2022 | -39.93% |
| Q3 2022 | -34.84% |
| Q2 2022 | -31.52% |
| Q1 2022 | -23.45% |
| Q4 2021 | -10.13% |
| Q3 2021 | -28.69% |
| Q2 2021 | 28.53% |
| Q1 2021 | -25.35% |
| Q4 2020 | -18.91% |
| Q3 2020 | -1.29% |
| Q2 2020 | -19.29% |
| Q1 2020 | -17.36% |
| Q4 2019 | -17.93% |
| Q3 2019 | -15.70% |
| Q2 2019 | 1920.47% |
| Q1 2019 | 25.89% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |